FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

Clinical trial NCT07515963 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07515963
Sponsor: Zhongnan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colo-rectal Cancer

Start date: 2026-06-01
Primary completion: 2027-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.